,i  #aacth ,,congress  #b;d ,session    
,h4 ,r4 #dejb  ,,in ,,the ,,house ,,of  
,,representatives  ,april #bh1 #bjad    
,mr4 ,luetkemeyer introduced the        
following bill2 which was referred to   
the ,committee on ,energy and ,commerce1
 and in addition to the ,committee on   
the ,judiciary1 for a period to be      
subsequently determined by the ,speaker1
 in each case for consideration of such 
provisions as fall within the           
jurisdiction of the committee concerned 
,a ,,bill  ,to authorize the ,attorney  
,general to exempt certain products from
 the requirements of subsections 7d7 and
 7e7 of section #caj of the ,controlled 
,substances ,act if it is not practical 
to use such products in the illicit     
manufacture of methamphetamine4  #a4    
,short title ,this ,act may be cited as 
the ,stop ,meth ,labs and ,enhance      
,patient ,access ,act of #bjad4  #b4    
,exemption if it is not practical to use
 product in illicit manufacture of      
methamphetamine ,section #caj7;e77#c7 of

 the ,controlled ,substances ,act 7#ba  
,u4,s4,c4 #hcj7;e77#c77 is amended by   
striking if the ,attorney ,general      
determines that the product cannot be   
used in the illicit manufacture of      
methamphetamine and inserting if the    
,attorney ,general determines that it is
 not practical by processes known to be 
employed by clandestine laboratory      
operators to use the product in the     
illicit manufacture of methamphetamine4